ELAB vs NI · rev $2.0M vs P/E 23, rev $3.61B
Elevai Labs, Inc. Common Stock (ELAB) versus NiSource Inc (NI) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
NiSource Inc (NI) is a utilities - regulated gas company listed on NYSE.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported NI revenue for 2026-06-30 was $3.61B. Net income was $552.6M. Revenue was up 55.5% from 2026-03-31 to 2026-06-30. NI currently screens at market cap $22.42B and trailing P/E 23.3.
ELAB currently screens at market cap $6.5M. NI currently screens at market cap $22.42B and trailing P/E 23.3.
Not investment advice. Open the ELAB and NI stock pages for the full models.
Not investment advice.